About CELMATIX INC
Celmatix Inc. is a US-based biotech company focused on women's health, developing novel therapeutics for conditions such as infertility, endometriosis, and ovarian aging. The company has received significant funding and recognition, including a $3.5 million award from ARPA-H’s Sprint for Women’s Health.
Development of first-in-class oral FSH receptor agonist for fertility careCreation of novel JNK inhibitor for endometriosis targeting pain and inflammationEarly-stage AMH-targeting antibodies for ovarian folliculogenesis controlUtilization of DNA-Encoded Chemistry Technology (DEC-Tec) platform for drug discovery
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CELMATIX INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.